A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
Titel:
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
Auteur:
Cummings, J.F. Polhemus, M.E. Kester, K.E. Ockenhouse, C.F. Gasser Jr., R.A. Coyne, P. Wortmann, G. Nielsen, R.K. Schaecher, K. Holland, C.A. Krzych, U. Tornieporth, N. Soisson, L.A. Angov, E. Heppner, D.G.